Vivotecnia
Private Company
Funding information not available
Overview
Vivotecnia is a Madrid-based preclinical and toxicology CRO offering end-to-end safety assessment services under GLP standards for pharmaceuticals, biocides, chemicals, cosmetics, and medical devices. Its competitive advantage lies in a strong process-driven environment, state-of-the-art facilities housing multiple species, and a commitment to the 3Rs and New Approach Methodologies (NAMs). With a client base spanning Europe, the Americas, and Asia, Vivotecnia positions itself as a trusted partner for generating critical data required for IND/IMPD and other regulatory submissions.
Technology Platform
Integrated preclinical service platform featuring GLP-certified in vivo (rodents, dogs, rabbits, minipigs, non-human primates) and in vitro laboratories, high-throughput bioanalytics, and a Part 11-compliant Provantis® data acquisition system. Employs 3Rs and New Approach Methodologies (NAMs).
Opportunities
Risk Factors
Competitive Landscape
Vivotecnia competes in the fragmented global preclinical CRO market against large, diversified players like Charles River Laboratories and Labcorp, as well as many regional and specialized toxicology CROs. Its differentiation is based on its European focus, full-service toxicology expertise, GLP certification, and commitment to the 3Rs.